# NALBUPHINE HYDROCHLORIDE
> **ANDA207595** · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2019-01-11
## Drug
- **FDA Application Number:** ANDA207595
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALBUPHINE HYDROCHLORIDE
- **Generic name:** Nalbuphine Hydrochloride
- **Active ingredients:** NALBUPHINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** RISING
- **First approval:** 2019-01-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207595)
---
*MORVS · CC0 1.0*